MENU
KAPA
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Kairos Pharma (KAPA) Ownership - Who owns Kairos Pharma?
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
2355 Westwood Boulevard, 139
Phone
+1 310 948-2356
Employees
3
Web
https://kairospharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.76M
P/E Ratio
N/A
Total Cash
3.62M
Projected Growth
N/A
Total Debt
142K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.21
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KAPA
Capitalization
8.76M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
3.62M
Total Cash/Share
0.21
Total Debt
142K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
7.13M
P/B Ratio
1.23
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
500K
Current Ratio
7.52
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-79.52
Shares Held By Institutions
1.49M
Shares Outstanding - Current
16.8M
Total Liabilities
805K
Total Volume MTD
N/A
Value
1
Gain YTD
-65.789
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2355 Westwood Boulevard, 139
Phone
+1 310 948-2356
Employees
3
Web
https://kairospharma.com